SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000441
Filing Date
2021-03-31
Accepted
2021-03-31 16:22:32
Documents
16
Period of Report
2021-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620436_8k-immunic.htm   iXBRL 8-K 22997
2 e620436_ex10-1.htm EX-10.1 36530
3 e620436_ex99-1.htm EX-99.1 15890
4 GRAPHIC image_001.jpg GRAPHIC 2421
5 GRAPHIC image_002.jpg GRAPHIC 3367
  Complete submission text file 0001193805-21-000441.txt   272179

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA imux-20210331.xsd EX-101.SCH 3059
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20210331_lab.xml EX-101.LAB 34238
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20210331_pre.xml EX-101.PRE 22381
9 EXTRACTED XBRL INSTANCE DOCUMENT e620436_8k-immunic_htm.xml XML 3695
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 21793653
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences